Australia's Cyclopharm hits near 3-month high on US supply agreement

Cyclopharm

03/10/2024 02:19

** Shares of Cyclopharm  CYC.AX  rise as much as 13.4% to
A$1.730, hitting their highest level since July 9
    ** Stock set for best session since early June, if gains
hold
    ** Radiopharmaceutical co signed agreement with U.S. Veteran
Administration to supply pharmaceutical and consumable
components of Technegas
    ** Technegas aids with recovery from respiratory diseases
such as chronic obstructive pulmonary disease
    ** Stock down 20.8% YTD, as of last close

 (Reporting by Shivangi Lahiri in Bengaluru)
 ((shivangi.lahiri@thomsonreuters.com))